Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1961 1
1966 1
1967 1
1969 1
1973 2
1976 1
1977 2
1978 4
1979 4
1980 8
1981 4
1982 7
1983 3
1984 7
1985 6
1986 10
1987 8
1988 11
1989 12
1990 11
1991 10
1992 11
1993 18
1994 12
1995 14
1996 15
1997 11
1998 18
1999 17
2000 26
2001 35
2002 24
2003 37
2004 48
2005 47
2006 53
2007 59
2008 58
2009 72
2010 98
2011 122
2012 155
2013 176
2014 210
2015 235
2016 310
2017 319
2018 354
2019 374
2020 410
2021 528
2022 554
2023 532
2024 562
2025 116

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,051 results

Results by year

Filters applied: . Clear all
Page 1
CAR-T Cell Therapy.
Ahmad A. Ahmad A. Int J Mol Sci. 2020 Jun 17;21(12):4303. doi: 10.3390/ijms21124303. Int J Mol Sci. 2020. PMID: 32560285 Free PMC article.
CAR-T therapy has revolutionized the treatment of select hematological malignancies, namely, acute lymphoblastic leukemia and large B-cell lymphomas [...]....
CAR-T therapy has revolutionized the treatment of select hematological malignancies, namely, acute lymphoblastic leukemia and large B
Comparison of Mulligan technique versus muscle energy technique in patients with adhesive capsulitis.
Khalil R, Tanveer F, Hanif A, Ahmad A. Khalil R, et al. J Pak Med Assoc. 2022 Feb;72(2):211-215. doi: 10.47391/JPMA.1678. J Pak Med Assoc. 2022. PMID: 35320163 Clinical Trial.
Group A had 11(28%) male and 28(72%) female patients, while Group B had 20(51%) male and 19(49%) female patients. Both groups showed significant improvement (p<0.001), and inter-group comparison showed the difference to be non-significant at baseline and third week (p&g …
Group A had 11(28%) male and 28(72%) female patients, while Group B had 20(51%) male and 19(49%) female patients. Both groups showed …
Methods of space maintenance for premature loss of a primary molar: a review.
Ahmad AJ, Parekh S, Ashley PF. Ahmad AJ, et al. Eur Arch Paediatr Dent. 2018 Oct;19(5):311-320. doi: 10.1007/s40368-018-0357-5. Epub 2018 Sep 5. Eur Arch Paediatr Dent. 2018. PMID: 30187262 Free PMC article. Review.
CONCLUSIONS: There was no strong evidence favouring a particular SM, the following recommendations were made: (a) strong recommendations: In cases where rubber dam cannot be used clinicians should not use Glass Fibre Reinforced Composite Resin (GFRCR) SMs. (b) Weak recomme …
CONCLUSIONS: There was no strong evidence favouring a particular SM, the following recommendations were made: (a) strong recommendations: In …
Apolipoprotein B in cardiovascular risk assessment.
Ahmad M, Sniderman AD, Hegele RA. Ahmad M, et al. CMAJ. 2023 Aug 28;195(33):E1124. doi: 10.1503/cmaj.230048. CMAJ. 2023. PMID: 37640407 Free PMC article. No abstract available.
X-Linked Agammaglobulinemia.
Lackey AE, Ahmad F. Lackey AE, et al. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31751055 Free Books & Documents.
The molecular basis for XLA is a disruption in B cell development due to mutation in Bruton's tyrosine kinase (Btk). Affected individuals inherit a defect that prevents precursor B cells in the bone marrow from forming mature, circulating B-lymphocytes that w …
The molecular basis for XLA is a disruption in B cell development due to mutation in Bruton's tyrosine kinase (Btk). Affected individ …
Reply to B.L. King-Kallimanis et al.
Friedman DR, Halwani AS, Kelley MJ. Friedman DR, et al. JCO Clin Cancer Inform. 2022 Jul;6:e2200075. doi: 10.1200/CCI.22.00075. JCO Clin Cancer Inform. 2022. PMID: 35878070 No abstract available.
Leukocyte Adhesion Deficiency.
Justiz Vaillant AA, Ahmad F. Justiz Vaillant AA, et al. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30969592 Free Books & Documents.
Leukocyte adhesion deficiency (LAD) is a defect of cellular adhesion molecules resulting in clinical syndromes. It is a combined (B cell) and cellular (T cell) immunodeficiency disorder. Major immunologic features: There is an inability to form pus. ...
Leukocyte adhesion deficiency (LAD) is a defect of cellular adhesion molecules resulting in clinical syndromes. It is a combined (B c …
Fructose-1-Phosphate Aldolase Deficiency.
Ahmad U, Sharma J. Ahmad U, et al. 2023 Apr 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Apr 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32491693 Free Books & Documents.
Fructose 1-phosphate aldolase deficiency or hereditary fructose intolerance (HFI) is an autosomal recessive disorder, caused by the deficiency in aldolase B (fructose-1, 6-bisphosphate aldolase), an enzyme responsible for the cleavage of fructose-1-phosphate. ...
Fructose 1-phosphate aldolase deficiency or hereditary fructose intolerance (HFI) is an autosomal recessive disorder, caused by the deficien …
5,051 results